Immutep IMMP
NASDAQ IMMP
$3.23 +0.06 (+1.89%)
As of: Oct 20, 2026 · 3:59 PM EDT

Immutep (IMMP) Restructuring Costs (2018 - 2019)

Updated

Immutep (IMMP) posted Restructuring Costs of $165,933 for the quarter ended Jun 30, 2019, down 55.6% from $373,588 a year earlier.

Analysis

Immutep (IMMP) Restructuring Costs (2018 - 2019) Analysis & Trends

  • In prior years, Immutep's Restructuring Costs was $382,660 in the year ended Jun 30, 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Immutep 23.95 Mn -187.07 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 165,932.78
Jun 30, 2018 373,587.88
API Access

Immutep Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=IMMP&period=max&api_key=YOUR_API_KEY